Research ArticleA randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Keywords: Lambda; peginterferon lambda-1a; alfa; peginterferon alfa-2a; GT1,4; HCV genotype 1 or 4; GT2,3; HCV genotype 2 or 3; cEVR; complete early virologic response; RVR; rapid virologic response; EOT; end-of-treatment; SVR12; sustained virologic response at pos